Source disclosure: February 13, 2026
Euglena Co., Ltd. [2931.T]
TOKYO, Feb 13 (Pulse News Wire) – Euglena CO.,LTD. (2931.T) reported a special loss of ¥197 million due to lower-than-expected performance by its subsidiaries.
The company also revised its forecasts for the fiscal year ended December 31, 2025. For the fiscal year ending December 31, 2025, Euglena's consolidated operating profit increased by ¥2.822 billion compared to the previous year, while net income attributable to shareholders decreased by ¥--¥155 million. Revenue grew by ¥2.751 billion, but ordinary profit saw a reduction of ¥1.933 billion.
In addition, individual performance showed a significant improvement in revenue, increasing by ¥1.199 billion. However, despite higher sales in the healthcare sector, the company still recorded a net loss of ¥-, marking a decrease from the previous year’s loss of ¥-. The adjustments reflect cost-cutting measures and reduced personnel expenses due to voluntary retirement programs.
Euglena expects ongoing improvements in operational efficiency and continued growth in the healthcare division to drive future profitability.
AI-translated content. 🟢 Confidence: High See terms • Original filing